Multidrug resistance protein functionality: No effect of intracellular or extracellular pH changes

Biochemical Pharmacology

Volumn 60, Issue 10, 2000, Pages 1485-1489

  Marbeuf Gueye, Carole ^a   Priebe, Waldemar ^b   Garnier Suillerot, Arlette ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Anthracycline; Doxorubicin; MRP1; Multidrug resistance; pH

Indexed keywords

ABC TRANSPORTER; ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; GLYCOPROTEIN P; HYDROXYRUBICIN; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL PH; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTON TRANSPORT; STRUCTURE ACTIVITY RELATION; SURFACE CHARGE; TRANSPORT KINETICS;

BIOLOGICAL TRANSPORT; CELL DIVISION; CYTOSOL; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; ENZYME INHIBITORS; EPIRUBICIN; HUMAN; HYDROGEN-ION CONCENTRATION; P-GLYCOPROTEIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0034670165     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00453-6     Document Type: Article

References (27)

1. Gottesman M.M., Pastan I., Ambudkar S.V. P-glycoprotein and multidrug resistance. Curr Biol. 6:1996;610-617.
2. Juranka P.F., Zastawny R.L., Ling V. P-glycoprotein, multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 3:1989;2583-2592.
3. Deeley R.G., Cole S.P. Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol. 8:1997;193-204.
4. Loe D.W., Deeley R.G., Cole S.P. Biology of drug resistance associated with overexpression of the multidrug resistance protein, MRP. Eur J Cancer. 32A:1996;945-957.
5. Higgins C.F. ABC Transporters From microorganisms to man . Annu Rev Cell Biol. 8:1992;67-113.
6. Cole S.P., Deeley R.G. Multidrug resistance mediated by the ATP-binding cassette transporter protein, MRP. Bioessays. 20:1998;931-940.
7. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 269:1994;27807-27810.
8. Feller N., Broxterman H.J., Währer D.C., Pinedo H.M. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP) No inhibition by intracellular glutathione depletion . FEBS Lett. 308:1995;385-388.
9. Versantvoort C.H., Broxterman H.J., Lankelma J., Feller N., Pinedo H.M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol. 48:1994;1129-1136.
10. Versantvoort C.H., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer. 72:1995;82-89.
11. Zaman G.J., Lankelma J., van Tellingen O., Beijen J., Dekker H., Paulusma C., Oudel Elferink R.P., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sc USA. 92:1995;7690-7694.
12. Marbeuf-Gueye C., Broxterman H.J., Dubru F., Priebe W., Garnier-Suillerot A. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Mol Pharmacol. 53:1998;141-147.
13. r 190,000 multidrug resistance protein Evidence for cotransport with reduced glutathione . Cancer Res. 58:1998;1-7.
14. Frézard F., Garnier-Suillerot A. Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells. Eur J Biochem. 196:1991;483-491.
15. Garnier-Suillerot A. Impaired accumulation of drug in multidrug resistant cells. What are the relative contributions of the kinetics of uptake and of P-glycoprotein-mediated efflux of drug? Curr Pharm Des. 1:1995;69-82.
16. Mankhetkorn S., Dubru F., Hesschenbrouck J., Fiallo M., Garnier-Suillerot A. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mol Pharmacol. 49:1996;532-539.
17. Priebe W. Mechanism of action-governed design of anthracycline antibiotics A "turn-off/turn-on" approach . Curr Pharm Des. 1:1995;51-68.
18. Zijlstra J.G., de Vries E.G., Mulder N.H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47:1987;1780-1784.
19. Frézard F., Garnier-Suillerot A. Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and-sensitive K562 cells. Biochim Biophys Acta. 1091:1991;29-35.
20. Borrel M.-N., Fiallo M., Veress I., Garnier-Suillerot A. The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells. Biochem Pharmacol. 50:1995;2069-2076.
21. Borrel M.-N., Pereira E., Fiallo M., Garnier-Suillerot A. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4′-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells. Eur J Biochem. 223:1994;125-133.
22. Pereira E., Borrel M.-N., Fiallo M., Garnier-Suillerot A. Non-competitive inhibition of P-glycoprotein-associated efflux of Thp-adriamycin by verapamil in living K562 leukemia cells. Biochim Biophys Acta. 1225:1994;209-216.
23. Borrel M.-N., Fiallo M., Priebe W., Garnier-Suillerot A. P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells. FEBS Lett. 356:1994;287-290.
24. Seksek O., Henry-Toulme N., Sureau F., Bolard J. SNARF-1 as an intracellular pH indicator in laser microspectrofluorometry A critical assessment . Anal Biochem. 193:1991;49-54.
25. Altenberg A.G., Young G., Horton J.K., Glass D., Belli J.A., Reuss L. Changes in intracellular or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci USA. 90:1993;9735-9738.
26. Asaoka K. Affinity purification and characterization of glutathione S-transferases from bovine liver. J Biochem. 95:1984;685-696.
27. Formicka-Kozlowska G., May P.M., Williams D.R. Inorg Chim Acta. 46:1980;L51.